Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2011 Mar;24(3):444-8.
doi: 10.3109/14767058.2010.497573. Epub 2010 Jul 7.

Pharmacokinetics of metronidazole in pregnant patients with bacterial vaginosis

Xin Wang  1 , Tatiana N Nanovskaya, Ying Zhan, Susan M Abdel-Rahman, Marlo Jasek, Gary D V Hankins, Mahmoud S Ahmed
Affiliations
Clinical Trial

Pharmacokinetics of metronidazole in pregnant patients with bacterial vaginosis

Xin Wang et al. J Matern Fetal Neonatal Med. 2011 Mar.

Abstract

Objective: The present study was undertaken to investigate the pharmacokinetics of metronidazole in pregnant patients with bacterial vaginosis.

Methods: Twenty patients received metronidazole (Flagyl ®, Pfizer, 235 East 42nd Street, NY, NY 10017) oral dose 500 mg twice a day for 3 consecutive days. Pharmacokinetic analyses of metronidazole were performed after a single oral dose on the morning of day 4.

Results: Although absolute estimates of metronidazole total body exposure were highest in women during early term pregnancy, weight-corrected estimates of exposure maximum plasma drug concentration (C(max)) and the area under the plasma concentration-versus-time curve (AUC(0-12)), along with apparent oral clearance and distribution volume, were not significantly different between women at early, middle, and late stages of pregnancy and were in the range of reported values for nonpregnant patients receiving a similar dose.

Conclusions: The pharmacokinetic profile of metronidazole did not change at the different time points assessed during pregnancy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Metronidazole plasma concentration-time profiles in early (circles), middle (squares), and late (diamonds) pregnancy after per os administration of 500 mg Flagyl®. Results were mean±SEM.
Figure 2
Figure 2
Metronidazole urinary excretion-time profiles in early (1), middle (2), and late (3) pregnancy after per os administration 500 mg Flagyl®. Results were mean±SEM.
See this image and copyright information in PMC

References

    1. Sobel JD. Vaginitis in Adult Women. Obstet Gynecol Clin North Am. 1990;17:851–79. - PubMed
    1. Eschenbach DA, Gravett MG, Chen KC, Hoyme UB, Holmes KK. Bacterial vaginosis during pregnancy. An association with prematurity and postpartum complications. Scand J Urol Nephrol. 1984;86 (suppl):213–22. - PubMed
    1. Gravett MG, Nelson HP, Derouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent Associations of Bacterial Vaginosis and Chlamydia-Trachomatis Infection with Adverse Pregnancy Outcome. JAMA. 1986;256:1899–903. - PubMed
    1. Kurki T, Sivonen A, Renkonen OV, Savia E, Ylikorkala O. Bacterial Vaginosis in Early-Pregnancy and Pregnancy Outcome. Obstet Gynecol. 1992;80:173–7. - PubMed
    1. Riduan JM, Hillier SL, Utomo B, Wiknjosastro G, Linnan M, Kandun N. Bacterial Vaginosis and Prematurity in Indonesia -Association in Early and Late Pregnancy. Am J Obstet Gynecol. 1993;169:175–8. - PubMed

Publication types

MeSH terms